We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$376M
AUM Growth
-$49.9M
Cap. Flow
-$71.2M
Cap. Flow %
-18.95%
Top 10 Hldgs %
30.78%
Holding
247
New
89
Increased
32
Reduced
48
Closed
42

Top Buys

Rank Stock Value
1
WBS icon
Webster Financial
WBS
+$8.18M
2
NFLX icon
Netflix
NFLX
+$8.12M
3
RH icon
RH
RH
+$7.6M
4
EBAY icon
eBay
EBAY
+$7.58M
5
TSLA icon
Tesla
TSLA
+$7.04M

Top Sells

Rank Stock Value
1
ASH icon
Ashland
ASH
+$11.5M
2
FFIV icon
F5
FFIV
+$10.4M
3
HCA icon
HCA Healthcare
HCA
+$9.96M
4
MMM icon
3M
MMM
+$9.59M
5
MCK icon
McKesson
MCK
+$9.56M

Sector Composition

Rank Sector Weight
1 Healthcare 19.36%
2 Consumer Discretionary 15.29%
3 Consumer Staples 11.75%
4 Financials 11.45%
5 Technology 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDC icon
126
Teradata
TDC
$2.55B
$9K ﹤0.01%
354
BN icon
127
Brookfield
BN
$108B
$8K ﹤0.01%
681
+225
+49% +$2.64K
HMC icon
128
Honda
HMC
$41.3B
$8K ﹤0.01%
238
+80
+51% +$2.59K
SH icon
129
ProShares Short S&P500
SH
$897M
$8K ﹤0.01%
46
TEVA icon
130
Teva Pharmaceuticals
TEVA
$41.2B
$8K ﹤0.01%
127
+45
+55% +$2.78K
VRTX icon
131
Vertex Pharmaceuticals
VRTX
$126B
$8K ﹤0.01%
65
FMX icon
132
Fomento Económico Mexicano
FMX
$41.7B
$7K ﹤0.01%
+78
New +$7.49K
NVS icon
133
Novartis
NVS
$297B
$7K ﹤0.01%
90
+32
+55% +$2.54K
KYO
134
DELISTED
Kyocera Adr
KYO
$7K ﹤0.01%
155
+54
+53% +$2.55K
SHPG
135
DELISTED
Shire pic
SHPG
$7K ﹤0.01%
36
-12
-25% -$2.49K
PEP icon
136
PepsiCo
PEP
$190B
$5K ﹤0.01%
49
+20
+69% +$2K
CDW icon
137
CDW
CDW
$17B
$4K ﹤0.01%
100
NEE icon
138
NextEra Energy
NEE
$177B
$4K ﹤0.01%
164
-156
-49% -$3.95K
AMZN icon
139
Amazon
AMZN
$2.96T
$3K ﹤0.01%
+80
New +$2.52K
ASH icon
140
Ashland
ASH
$3.5B
$3K ﹤0.01%
55
-218,962
-100% -$11.5M
BKNG icon
141
Booking.com
BKNG
$161B
$3K ﹤0.01%
+50
New +$2.64K
SEE
142
DELISTED
Sealed Air
SEE
$3K ﹤0.01%
60
AAPL icon
143
Apple
AAPL
$4.57T
$2K ﹤0.01%
68
-240
-78% -$6.86K
ABT icon
144
Abbott
ABT
$187B
$2K ﹤0.01%
+48
New +$2.12K
ACN icon
145
Accenture
ACN
$108B
$2K ﹤0.01%
+19
New +$2K
ADBE icon
146
Adobe
ADBE
$105B
$2K ﹤0.01%
+23
New +$2.07K
AIG icon
147
American International
AIG
$41.3B
$2K ﹤0.01%
+33
New +$2.01K
BA icon
148
Boeing
BA
$185B
$2K ﹤0.01%
+14
New +$2.02K
BAC icon
149
Bank of America
BAC
$442B
$2K ﹤0.01%
+123
New +$2.08K
BMY icon
150
Bristol-Myers Squibb
BMY
$132B
$2K ﹤0.01%
+31
New +$2.05K

Similar funds

Contravisory Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Contravisory Investment Management held 247 positions worth $376M, down 12% from $425M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Contravisory Investment Management withdrew a net $71.2M in Q4 2015, closing 42 positions and reducing 48 holdings. Its most notable exit was F5, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Contravisory Investment Management opened a new position in Webster Financial worth $8.03M.

  • Contravisory Investment Management's largest Q4 2015 buy was Webster Financial: 215,895 shares worth $8.03M.
  • Contravisory Investment Management added most to State Street Technology Select Sector SPDR ETF in Q4 2015, an estimated $719K increase.
  • Contravisory Investment Management's biggest Q4 2015 reduction was Ashland, cutting an estimated $11.5M.
  • Contravisory Investment Management fully exited F5 in Q4 2015, selling an estimated $10.4M.
  • Contravisory Investment Management's ten largest holdings make up 31% of its $376M portfolio in Q4 2015.
  • Contravisory Investment Management opened 89 new positions and closed 42 in Q4 2015.
  • Contravisory Investment Management's portfolio value fell 12% quarter-over-quarter to $376M.

Based on Contravisory Investment Management's 13F filing for Q4 2015, filed 12 Jan 2016.